These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 7773555)
21. Upregulation of striatal D2 receptors in the MPTP-treated vervet monkey is reversed by grafts of fetal ventral mesencephalon: an autoradiographic study. Elsworth JD; Brittan MS; Taylor JR; Sladek JR; Redmond DE; Innis RB; Zea-Ponce Y; Roth RH Brain Res; 1998 Jun; 795(1-2):55-62. PubMed ID: 9622593 [TBL] [Abstract][Full Text] [Related]
22. Improvements in MPTP-induced object retrieval deficits and behavioral deficits after fetal nigral grafting in monkeys. Taylor JR; Elsworth JD; Roth RH; Collier TJ; Sladek JR; Redmond DE Prog Brain Res; 1990; 82():543-59. PubMed ID: 2290957 [TBL] [Abstract][Full Text] [Related]
23. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Widner H; Tetrud J; Rehncrona S; Snow B; Brundin P; Gustavii B; Björklund A; Lindvall O; Langston JW N Engl J Med; 1992 Nov; 327(22):1556-63. PubMed ID: 1435882 [TBL] [Abstract][Full Text] [Related]
24. Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates. Albanese A; Granata R; Gregori B; Piccardi MP; Colosimo C; Tonali P Neuroscience; 1993 Aug; 55(3):823-32. PubMed ID: 8105418 [TBL] [Abstract][Full Text] [Related]
25. Neurochemical evaluation of the striatum in symptomatic and recovered MPTP-treated cats. Schneider JS; Rothblat DS Neuroscience; 1991; 44(2):421-9. PubMed ID: 1944893 [TBL] [Abstract][Full Text] [Related]
26. Efferent synaptic connections of dopaminergic neurons grafted into the caudate nucleus of experimentally induced parkinsonian monkeys are different from those of control animals. Leranth C; Sladek JR; Roth RH; Redmond DE Exp Brain Res; 1998 Dec; 123(3):323-33. PubMed ID: 9860271 [TBL] [Abstract][Full Text] [Related]
27. MPTP-induced parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms. Crossman AR; Clarke CE; Boyce S; Robertson RG; Sambrook MA Can J Neurol Sci; 1987 Aug; 14(3 Suppl):428-35. PubMed ID: 3119180 [TBL] [Abstract][Full Text] [Related]
28. Behavioral and biochemical studies in monkeys made hemiparkinsonian by MPTP. Brooks BA; Eidelberg E; Morgan WW Brain Res; 1987 Sep; 419(1-2):329-32. PubMed ID: 3499952 [TBL] [Abstract][Full Text] [Related]
29. Continued presence of intrastriatal but not intraventricular polymer-encapsulated PC12 cells is required for alleviation of behavioral deficits in Parkinsonian rodents. Emerich DF; Winn SR; Lindner MD Cell Transplant; 1996; 5(5):589-96. PubMed ID: 8889217 [TBL] [Abstract][Full Text] [Related]
30. Motor and nonmotor behavioral deficits in monkeys made hemiparkinsonian by intracarotid MPTP infusion. Schneider JS; McLaughlin WW; Roeltgen DP Neurology; 1992 Aug; 42(8):1565-72. PubMed ID: 1641154 [TBL] [Abstract][Full Text] [Related]
31. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model. Di Monte DA; McCormack A; Petzinger G; Janson AM; Quik M; Langston WJ Mov Disord; 2000 May; 15(3):459-66. PubMed ID: 10830409 [TBL] [Abstract][Full Text] [Related]
32. Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex. Calon F; Goulet M; Blanchet PJ; Martel JC; Piercey MF; Bédard PJ; Di Paolo T Brain Res; 1995 May; 680(1-2):43-52. PubMed ID: 7663983 [TBL] [Abstract][Full Text] [Related]
33. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy. Kastner A; Herrero MT; Hirsch EC; Guillen J; Luquin MR; Javoy-Agid F; Obeso JA; Agid Y Ann Neurol; 1994 Aug; 36(2):206-14. PubMed ID: 7914399 [TBL] [Abstract][Full Text] [Related]
34. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy. Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606 [TBL] [Abstract][Full Text] [Related]
35. Differential recovery of volitional motor function, lateralized cognitive function, dopamine agonist-induced rotation and dopaminergic parameters in monkeys made hemi-parkinsonian by intracarotid MPTP infusion. Schneider JS; Lidsky TI; Hawks T; Mazziotta JC; Hoffman JM Brain Res; 1995 Feb; 672(1-2):112-7. PubMed ID: 7749732 [TBL] [Abstract][Full Text] [Related]
36. Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. Dluzen D; Jain R; Liu B J Neurochem; 1994 Jan; 62(1):94-101. PubMed ID: 8263548 [TBL] [Abstract][Full Text] [Related]
37. In vivo changes of catecholamines in hemiparkinsonian monkeys measured by microdialysis. Skirboll S; Wang J; Mefford I; Hsiao J; Bankiewicz KS Exp Neurol; 1990 Nov; 110(2):187-93. PubMed ID: 1699780 [TBL] [Abstract][Full Text] [Related]
38. Drug-induced dyskinesia in primates rendered hemiparkinsonian by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Clarke CE; Boyce S; Robertson RG; Sambrook MA; Crossman AR J Neurol Sci; 1989 May; 90(3):307-14. PubMed ID: 2786926 [TBL] [Abstract][Full Text] [Related]
39. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins. Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585 [TBL] [Abstract][Full Text] [Related]
40. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Pifl C; Schingnitz G; Hornykiewicz O Neuroscience; 1991; 44(3):591-605. PubMed ID: 1754053 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]